Key Trends and Insights into the Closed System Transfer Devices Market: Growth Rate and Opportunities to 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What Future CAGR is Anticipated for the Closed System Transfer Devices Market Over the 2025–2034 Period?
The market size of closed system transfer devices has experienced significant expansion in the past few years. The industry, which was valued at $1.04 billion in 2024, is projected to rise to $1.19 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.5%. Factors contributing to the historical growth include the surge in oncology drug approvals, heightened attention towards occupational safety, a growing need to prevent needle-stick injuries and contact with dangerous drugs, amplified awareness of the risks associated with exposure to cytotoxic drugs, and an increase in the chemotherapy patient population.
The market for closed system transfer devices is set to experience significant expansion in the upcoming years, with an anticipated growth to $2.03 billion in 2029, indicating a compound annual growth rate (CAGR) of 14.3%. Factors contributing to this projected growth during the forecast period include the rising prevalence of cancer, the heightened need for compliance monitoring to ensure safe handling of harmful medications, increased awareness of closed system transfer devices, the growing use of CSTDS for delivering hazardous drugs, and the increasing number of drug approvals related to cancer. The key trends anticipated in the future encompass launch of new products and heightened focus on safety, creation of digital platforms and tools meant for user convenience, a surge in research and development efforts, technological progress, and a growing reliance on membrane-to-membrane systems.
Which Primary Drivers Are Supporting the Continued Expansion of the Closed System Transfer Devices Market?
The closed-system transfer devices market is poised to grow due to the escalating prevalence of cancer, a condition marked by the anarchic multiplication of abnormal cells that can infiltrate adjacent tissues and metastasize through the circulatory and lymphatic systems. The surge in cancer occurrences can be attributed to several factors, including lifestyle conditions, environmental contaminants, and growing infection rates. Closed-system transfer devices play a critical role in cancer therapy as they safeguard healthcare professionals and patients from risks linked to chemotherapy drug handling and administration. Their utilization enhances healthcare safety and improves patient outcomes in cancer treatment. For instance, data from the World Health Organization (WHO), a Switzerland-based intergovernmental body, in February 2024 predicts that by 2050, the number of cancer cases will soar to over 35 million, a 77% increase from the approximated 20 million cases anticipated for 2022. This considerable increase underscores the escalating cancer burden globally. Moreover, the National Center for Biotechnology Information, a US government body, reported in January 2023 that the number of new cancer cases in the US was 1,958,310 and projected cancer-related fatalities in 2023 to reach 609,820. Consequently, the escalating numbers of cancer cases are pushing the growth of the closed system transfer devices market.
Request Your Free Closed System Transfer Devices Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15767&type=smp
Who Are the Influential Players Fueling Innovation and Growth in the Closed System Transfer Devices Market?
Major companies operating in the closed system transfer devices market are:
• Cardinal Health Inc.
• Becton Dickinson and Company
• Baxter International Inc.
• Corning Incorporated
• B Braun Melsungen AG
What Impact Are Industry Trends Having on the Closed System Transfer Devices Market’s Future Prospects?
Firms that are major players in the closed system transfer devices (CSTD) market are now concentrating on creating innovative syringe units. The goal is to heighten safety, enhance the user experience, lower contamination risk and comply with rigorous regulatory rules within the healthcare sector. A syringe particularly designed to deliver or dispense the entire volume of liquid or medication it holds, without needing further mixing or dilution, is known as a full volume use syringe. An example of this would be Equashield, a US medical device firm, that in October 2023, launched the EQUASHIELD Syringe Unit. This unit has been given FDA approval for full-volume use, offering a safer and more efficient way to handle dangerous drugs. This cutting-edge design stops vapour leakage and prevents plunger contamination, making it a cost-effective solution for compounding and administering medications.
Pre-order Your Report for Quick and Easy Delivery!
Which Industry Segments Are Leading the Development and Expansion of the Closed System Transfer Devices Market?
The closed system transfer devices market covered in this report is segmented –
1) By Type: Needleless Systems, Membrane-To-Membrane Systems
2) By Technology: Diaphragm-Based, Compartmentalized, Filtration
3) By Closing Mechanism: Color-To-Color Alignment Systems, Push-To-Turn Systems, Click-To-Lock Systems, Luer-Lock Systems
4) By End User: Hospitals And Clinics, Oncology Centers, Other End Users
Subsegments:
1) By Needleless Systems: Closed Vial Systems, Closed Syringe Systems, Transfer Device Adapters
2) By Membrane-To-Membrane Systems: Membrane-To-Membrane Transfer Devices, Filtered Membrane Transfer Devices
What Regions Are Leading the Growth Trajectory of the Closed System Transfer Devices Market?
North America was the largest region in the closed system transfer device market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the closed system transfer devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Are the Defining Aspects of the Closed System Transfer Devices Market Landscape?
Closed system transfer devices (CSTDs) are specialized drug transfer devices designed to mechanically prevent environmental contaminants from entering the system and to stop hazardous drugs or vapor concentrations from escaping. These devices create a closed, leak-proof system to ensure the safe handling of hazardous substances in healthcare environments.
Browse Through More Similar Reports By The Business Research Company:
Orthopedic Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/orthopedic-devices-global-market-report
Cardiovascular Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report
Computer Storage Devices And Servers Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
